The physical and digital biobank supports the integration of artificial intelligence in acute care diagnostics development.

Last week, readers were most interested in a story about concerns about BillionToOne's Unity NIPT due to false negative results.

The tests run on the company's TruVerus benchtop instrument, which provides results from a blood sample in minutes.

The company said its preliminary revenues for the fourth quarter were at least $21 million, and its full-year 2025 revenues are expected to grow to $77 million.

The firm said it has appointed Abhishek Jain, a veteran of CareDx and Agilent Technologies, to be its next chief financial officer.

For full-year 2025, MDxHealth's preliminary revenues are $109 million, up 21 percent from 90.0 million in 2024. It billed 49,180 tissue-based units, up from 18 percent year over year, and 71,920 ...

The bill was one of several discussed during a Thursday hearing by the Health Subcommittee of the House of Representatives' ...

NEW YORK – Cardiovascular testing firm Prevencio and Quadrant Health said Thursday that they have entered an agreement to integrate Prevencio's HART CVE and HART CADhs blood tests into Quadrant's ...

The next phase of funding will allow the team to launch a clinical trial to test a novel way of making early gastric tumors easier to identify during endoscopy procedures.

NEW YORK – ShanX Medtech, an in vitro diagnostics developer based in The Netherlands, announced on Thursday that it has raised €15 million ($17.5 million) in an oversubscribed seed funding round.